grant

CORE B: GENOMICS CORE

Organization EMORY UNIVERSITYLocation ATLANTA, UNITED STATESPosted 1 Sept 2003Deadline 31 Jul 2029
NIHUS FederalResearch GrantFY20252019 novel corona virus2019 novel coronavirus2019-nCoV2019-nCoV S protein2019-nCoV spike glycoprotein2019-nCoV spike protein2019-nCoV variant2019-nCoV variant forms2019-nCoV variant strainsATAC sequencingATAC-seqATACseqAb-mediated immunityAb-mediated protectionAccelerationAdaptive Immune SystemAddressAlgorithmsAntibodiesAntibody immunityAntibody protectionAntibody-mediated protectionAntigenic DeterminantsAntigensAssayAssay for Transposase-Accessible Chromatin using sequencingB blood cellsB cellB cell repertoireB cellsB-CellsB-LymphocytesB-cellBar CodesBasal Transcription FactorBasal transcription factor genesBenchmarkingBest Practice AnalysisBinding DeterminantsBioassayBioinformaticsBiological AssayBody TissuesCOVID crisisCOVID epidemicCOVID pandemicCOVID-19 S proteinCOVID-19 antibodyCOVID-19 crisisCOVID-19 epidemicCOVID-19 eraCOVID-19 global health crisisCOVID-19 global pandemicCOVID-19 health crisisCOVID-19 pandemicCOVID-19 periodCOVID-19 public health crisisCOVID-19 spikeCOVID-19 spike glycoproteinCOVID-19 spike proteinCOVID-19 vaccinationCOVID-19 variantCOVID-19 variant formsCOVID-19 variant strainsCOVID-19 virusCOVID-19 yearsCOVID19 virusCadaverCell BodyCellsCellular biologyChromatinCoV S proteinCoV glycoprotein SCoV spike glycoproteinCoV spike proteinCoV-2CoV2ComplexCoronavirus glycoprotein SCoronavirus spike proteinDNADataDeoxyribonucleic AcidDevelopmentEmergent TechnologiesEmerging TechnologiesEpitopesEvolutionExpression SignatureFundingGene ExpressionGene Expression ProfileGene TranscriptionGeneral Transcription Factor GeneGeneral Transcription FactorsGeneralized GrowthGenetic TranscriptionGenomicsGoalsGrowthHumanHumoral ImmunitiesIg GenesImmuneImmune GlobulinsImmune responseImmunesImmunityImmunoglobulin GenesImmunoglobulinsImmunologic ReceptorsImmunological ReceptorsImmunologyIndividualInfectionInnate Immune SystemLibrariesLinkMacrophageMapsMeasuresMethodologyMethodsModalityModern ManModernizationNeighborhoodsOligoOligonucleotidesPhenotypePopulationProteinsRNA ExpressionReceptor ProteinRegimenResearchResolutionRoleSARS VirusSARS corona virusSARS corona virus 2SARS coronavirusSARS-Associated CoronavirusSARS-CO-V2SARS-COVID-2SARS-CoVSARS-CoV-1SARS-CoV-2SARS-CoV-2 SSARS-CoV-2 S proteinSARS-CoV-2 antibodySARS-CoV-2 epidemicSARS-CoV-2 global health crisisSARS-CoV-2 global pandemicSARS-CoV-2 pandemicSARS-CoV-2 pathogenesisSARS-CoV-2 spikeSARS-CoV-2 spike glycoproteinSARS-CoV-2 spike proteinSARS-CoV-2 vaccinationSARS-CoV-2 variantSARS-CoV-2 variant formsSARS-CoV-2 variant strainsSARS-CoV2SARS-Related CoronavirusSARS-associated corona virus 2SARS-associated coronavirus 2SARS-coronavirus-2SARS-coronavirus-2 epidemicSARS-coronavirus-2 pandemicSARS-related corona virus 2SARS-related coronavirus 2SARSCoV2SamplingSevere Acute Respiratory CoronavirusSevere Acute Respiratory Coronavirus 2Severe Acute Respiratory Distress Syndrome CoV 2Severe Acute Respiratory Distress Syndrome Corona Virus 2Severe Acute Respiratory Distress Syndrome Coronavirus 2Severe Acute Respiratory Syndrome CoV 2Severe Acute Respiratory Syndrome CoV 2 epidemicSevere Acute Respiratory Syndrome CoV 2 pandemicSevere Acute Respiratory Syndrome VirusSevere Acute Respiratory Syndrome corona virusSevere Acute Respiratory Syndrome coronavirusSevere Acute Respiratory Syndrome-associated coronavirus 2Severe Acute Respiratory Syndrome-related coronavirus 2Severe acute respiratory syndrome associated corona virus 2Severe acute respiratory syndrome coronavirus 2Severe acute respiratory syndrome coronavirus 2 S proteinSevere acute respiratory syndrome coronavirus 2 epidemicSevere acute respiratory syndrome coronavirus 2 pandemicSevere acute respiratory syndrome coronavirus 2 spike glycoproteinSevere acute respiratory syndrome coronavirus 2 spike proteinSevere acute respiratory syndrome coronavirus 2 vaccinationSevere acute respiratory syndrome related corona virus 2SpecificitySurfaceT-Cell SubsetsT-Lymphocyte SubsetsTechnologyTissue GrowthTissuesTranscriptionTranscription Factor Proto-OncogeneTranscription factor genesVaccinationVaccineeVaccinesValidationVariantVariationWorkWuhan coronavirusacquired immune systemagedantibody against COVID-19antibody against SARS-CoV-2antibody against coronavirus disease 2019antibody against severe acute respiratory syndrome coronavirus 2antibody to COVID-19antibody to SARS-CoV-2antibody to coronavirus disease 2019antibody to severe acute respiratory syndrome coronavirus 2antibody-based immunityantibody-mediated immunityassay for transposase accessible chromatin followed by sequencingassay for transposase accessible chromatin seqassay for transposase accessible chromatin sequencingassay for transposase-accessible chromatin with sequencingbarcodebenchmarkcadavericcadaverscell biologycohortcoronavirus S proteincoronavirus disease 2019 S proteincoronavirus disease 2019 antibodycoronavirus disease 2019 crisiscoronavirus disease 2019 epidemiccoronavirus disease 2019 global health crisiscoronavirus disease 2019 global pandemiccoronavirus disease 2019 health crisiscoronavirus disease 2019 pandemiccoronavirus disease 2019 public health crisiscoronavirus disease 2019 spike glycoproteincoronavirus disease 2019 spike proteincoronavirus disease 2019 vaccinationcoronavirus disease 2019 variantcoronavirus disease 2019 variant formscoronavirus disease 2019 variant strainscoronavirus disease 2019 viruscoronavirus disease crisiscoronavirus disease epidemiccoronavirus disease pandemiccoronavirus disease-19 global pandemiccoronavirus disease-19 pandemiccoronavirus disease-19 viruscoronavirus spike glycoproteindevelopmentalgene expression patterngene expression signaturegenome profilinggenome scalegenome-widegenomewidegenomic profilingglobal gene expressionglobal transcription profilehCoV19high dimensionalityhost responsehuman dataimmune receptorimmune system responseimmunogenimmunoresponseinsightmulti-modalitymultimodalitynCoV2neutralizing antibodynew technologynovelnovel technologiesoligosontogenyprotein profilingpublic repositorypublicly accessible repositorypublicly available repositoryreceptorresolutionsresponsescRNA sequencingscRNA-seqsenescencesenescentsevere acute respiratory syndrome coronavirus 2 antibodysevere acute respiratory syndrome coronavirus 2 global health crisissevere acute respiratory syndrome coronavirus 2 global pandemicsevere acute respiratory syndrome coronavirus 2 pathogenesissevere acute respiratory syndrome coronavirus 2 variantsevere acute respiratory syndrome coronavirus 2 variant formssevere acute respiratory syndrome coronavirus 2 variant strainssevere acute respiratory syndrome-CoVsingle cell RNA-seqsingle cell RNAseqsingle cell expression profilingsingle cell genomicssingle cell technologysingle cell transcriptomic profilingsingle-cell RNA sequencingsocial rolespatial RNA sequencingspatial gene expression analysisspatial gene expression profilingspatial resolved transcriptome sequencingspatial transcriptome analysisspatial transcriptome profilingspatial transcriptome sequencingspatial transcriptomicsspatially resolved transcriptomicsspatio transcriptomicsspike proteins on SARS-CoV-2tech developmenttechnology developmenttooltranscription factortranscriptional profiletranscriptional signaturetranscriptomevaccinate against COVID-19vaccinate against SARS-CoV-2vaccinate against coronavirus disease 2019vaccinate against severe acute respiratory syndrome coronavirus 2vaccinated individualvaccinated participantvaccinated patientvaccinated personvaccinated subjectvaccination against COVID-19vaccination against SARS-CoV-2vaccination against Severe acute respiratory syndrome coronavirus 2vaccination against coronavirus disease 2019validations
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

ABSTRACT/SUMMARY:
Single-cell genomic technology has rapidly transformed modern immunology. In relatively few short years,

single-cell RNA sequencing has become near ubiquitous, primarily due to the availability of robust commercial

platforms. The ability to combine multiple forms of information simultaneously (i.e. multi-modal readouts) has…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →